Silver Book Fact

Effectiveness of treating ischemic strokert-PA within 3 hours of symptom onset

A study of the  victims with effectiveness of treating ischemic strokert-PA within 3 hours of symptom onset showed a decrease in rehabilitation costs of $1.4 million and nursing home costs of $4.8 million, per 1,000 eligible rt-PA-treated patients.

Fagan, SC, LB Morgenstern, A Petitta, RE Ward, BC Tilley, JR Marler, SR Levine, JP Broderick, TG Kwiatkowski, M Frankel, TG Brott, and MD Walker; for the NINDS rt-PA Stroke Study Group. Cost- Effectiveness of Tissue Plasminogen Activator for Acute Ischemic Stroke. Neurology. 1998; 50(4): 883-890. http://www.neurology.org/content/50/4/883.abstract

Reference

Title
Cost- Effectiveness of Tissue Plasminogen Activator for Acute Ischemic Stroke
Publication
Neurology
Publication Date
1998
Authors
Fagan, SC, LB Morgenstern, A Petitta, RE Ward, BC Tilley, JR Marler, SR Levine, JP Broderick, TG Kwiatkowski, M Frankel, TG Brott, and MD Walker; for the NINDS rt-PA Stroke Study Group
Volume & Issue
Volume 50, Issue 4
Pages
883-890
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • A study looking at the effects of cardiovascular medicines in elderly patients who had previous heart attacks, found a total death rate reduction of 24% between 1995 and 2004.  
  • Between 1984 and 1998, the cost of treating heart attack patients rose $10,000. However, medical technology increased the life expectancy of heart attack patients by an average of 1 year-a…  
  • Statin treatment soon after an acute heart attack reduces the risk of fatal heart disease or a recurrent heart attack by 24%.  
  • Effectiveness of treating ischemic stroke victims with rt-PA within 3 hours of symptom onset
    A study of the effectiveness of treating ischemic stroke victims with rt-PA within 3 hours of symptom onset found an estimated impact on long-term health outcomes of 564 quality-adjusted life-years saved…  
  • Undertreatment of patients with sSAS
    AS is often undertreated — one study found that 56% of severe symptomatic aortic stenosis (sSAS) patients referred to a cardiothoracic surgeon were not operated on.